clear

Creating new perspectives since 2009

COVID-19: Turkey set for 1st human virus vaccine trial

October 9, 2020 at 9:05 pm

Female lab technicians conduct tests as vaccine works for coronavirus (COVID-19) continue at Ege University’s Research and Application Center of Drug Development and Pharmocokinetics in Izmir, Turkey on 7 October 2020. [Lokman İlhan – Anadolu Agency]

Turkey will register its first human vaccine trial for the novel coronavirus probably in two weeks, the country’s health minister said on Friday, Anadolu reports.

“The subjects will be given the first dose after being kept in quarantine for five days and undergoing all necessary examinations,” Fahrettin Koca said at a news conference in the southern Adana province.

On the virus situation in Turkey, the minister urged people not to let down their guard and continue following COVID-19 safety rules.

He said the number of virus cases is dropping in all Turkish cities except Istanbul.

He asserted that Turkey has proven that it has an exceptional public health system, with its success during the pandemic also being hailed as an example by the World Health Organization.

“Our state is carrying out this fight [against COVID-19] with great success. We are one of the countries that are on the way to getting out of this crisis with the least damage,” Koca added.

READ: Russia to supply Egypt with 25m doses of coronavirus vaccine 

He said the overall occupancy rate for hospital beds in Turkey is 48% at the moment, 68% for intensive care units, and 31% for ventilators.

He said Turkey has a total of 11,800 filiation teams and 35,400 filiation personnel, which is more than the number of doctors engaged in the fight against COVID-19 in some countries.

Across the world, COVID-19 has claimed more than 1.06 million lives in 188 countries and regions since last December.

The US, India, and Brazil are currently the worst-hit countries.

More than 36.69 million cases have been reported worldwide, with recoveries over 25.5 million, according to figures compiled by the US-based Johns Hopkins University.